The pharmaceutical giant has settled the vast majority of cases around its drug Zantac in the US, boosting investor ...

Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion) settlement to resolve tens of thousands of lawsuits in the US over its discontinued heartburn drug ...

Lawsuits against the companies began piling up in both state and federal courts after the US Food and Drug Administration in ...

The product reduces the amount of acid the stomach makes, and was a best-seller in the UK and US in the early 1980s in treating indigestion, heartburn and acid reflux. It was the first drug to ...

“They sort of help with neutralizing that excess, stomach acid production,” says pharmacist Brianna Pallot. “Heartburn is ...

Shares in GSK have jumped after a settlement with heart drug users in the US (Andy Buchanan/PA) Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion ...

Dr Ahmed, a GP based in the UK, took to TikTok to issue the warning, saying: "I bet the vast majority of you have even been ...

GSK shares in London jumped 5% Thursday after the British drug giant said it has resolved most of the U.S. lawsuits it faced ...